FDA Drug Application (090872) for SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number090872
Product Number001
FormTABLET; ORAL
Dosage85MG; 500MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSUMATRIPTAN SUCCINATE; NAPROXEN SODIUM
Active IngredientSUMATRIPTAN SUCCINATE; NAPROXEN SODIUM

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN SODIUM12
List of drugs with Active Ingredient SUMATRIPTAN SUCCINATE10


Back to FDA Applications sponsored by MYLAN PHARMS INC